NICHOLAS J. SIMON

Profile

First Name

: NICHOLAS

Middle Name

: J.

Last Name

: SIMON

Related Companies
Titles
Company Name
Related People
DIRECTOR
ACHILLION PHARMACEUTICALS INC
MILIND S. DESHPANDE, MARY KAY FENTON, JASON S. FISHERMAN, GARY E. FRASHIER, MICHAEL GREY, MICHAEL D. KISHBAUCH, DENNIS C. LIOTTA, ELIZABETH OLEK, DAVID I. SCHEER, GAUTAM SHAH, JOSEPH TRUITT, ROBERT L. VAN NOSTRAND, DAVID P. WRIGHT
DIRECTOR
PEARL THERAPEUTICS INC
CHARLES BRAMLAGE, SARVAJNA DWIVEDI, KEVIN FERRO, MICHAEL GOLDEN, STEVEN JAHARIS, SUNDAR KODIJALAM, SUNDAR KODIYALAM, THOMAS KOESTLER, KATHY LAPORTE, JAMES NIEDEL, CHADWICK OREVILLO, WILLIAM PICHT, JR., COLIN REISNER, HOWARD ROSEN, HOWARD B. ROSEN, NICHOLAS SIMON, JAMES YOUNG, JAMES W. YOUNG
EXECUTIVE OFFICER
CLARUS LIFESCIENCES III, L.P.
N/A CLARUS VENTURES III GP, L.P., N/A CLARUS VENTURES III, LLC, NICHOLAS GALAKATOS, DENNIS HENNER, ROBERT W. LIPTAK, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS DEFINED EXIT I, L.P.
N/A CLARUS VENTURES DE GP, L.P., N/A CLARUS VENTURES DE GP, LLC, NICHOLAS GALAKATOS, DENNIS HENNER, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS DE II, L.P.
N/A CLARUS VENTURES DE GP, L.P., N/A CLARUS VENTURES DE GP, LLC, NICHOLAS GALAKATOS, DENNIS HENNER, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS IV-D, L.P.
N/A CLARUS IV GP, L.P., N/A CLARUS IV GP, LLC, EMMETT CUNNINGHAM, NICHOLAS GALAKATOS, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS IV-C, L.P.
N/A CLARUS IV GP, L.P., N/A CLARUS IV GP, LLC, EMMETT CUNNINGHAM, NICHOLAS GALAKATOS, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS IV-B, L.P.
N/A CLARUS IV GP, L.P., N/A CLARUS IV GP, LLC, EMMETT CUNNINGHAM, NICHOLAS GALAKATOS, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
EXECUTIVE OFFICER
CLARUS IV-A, L.P.
N/A CLARUS IV GP, L.P., N/A CLARUS IV GP, LLC, EMMETT CUNNINGHAM, NICHOLAS GALAKATOS, ROBERT W. LIPTAK, SCOTT REQUADT, KURT C. WHEELER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-05-17
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-05-05 
2017-05-17
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-05-05 
2017-05-17
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-05-05 
2017-05-17
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-05-05 
2014-09-18
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-09-10 
2014-08-05
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-07-25 
2014-06-19
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-02-07 
2012-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-29 
2012-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-06-12 
2010-08-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-08-20